OGT and cancer: Under physiological conditions, O‐GlcNAcylation levels are maintained by a balanced ‘write–erase’ cycle; in pathological states such as cancer, overexpression of OGT or loss of OGA activity disrupts this homeostasis, driving malignancy through reprogramming of metabolic, epigenetic and signalling networks.